New Drug Extends Lives, Relieves Pain for Prostate Cancer

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
New Drug Extends Lives, Relieves Pain for Prostate Cancer Patients

PLEASANT HILL, Calif., Jan. 22, 2014 (GLOBE NEWSWIRE) -- For men suffering from advanced stage prostate cancer, a new drug is showing promise to extend survival time, improve quality of life and ease pain from cancer that has metastasized to the bones.

Approved by the FDA last spring, Xofigo is intended for patients with castration-resistant prostate cancer (CRPC), an advanced form of prostate cancer, which has become resistant to medical or surgical treatments that lower testosterone. Pacific Urology and partnering clinic Diablo Valley Oncology (DVO) are among the first practices in the East San Francisco Bay Area to offer Xofigo to their patients.

Xofigo is an injectable radioactive drug that chemically mimics calcium and binds to minerals in bone to deliver radiation directly to bone tumors, thereby limiting damage to surrounding tissues.

"Xofigo is showing great promise for advanced prostate cancer patients," says Dr. Brian Hopkins of Pacific Urology, who championed efforts to bring the drug to his Bay Area practice. "This development broadens our approach to treating such a potentially devastating cancer."

In July 2013, The New England Journal of Medicine published results of a study showing Xofigo improved survival rates in men with advanced prostate cancer.

"This drug has tolerable side effects and has the potential to ease pain, slow the weakening of affected bones and possibly also prolong their lives," says Dr. Sachin Kamath , a DVO radiation oncologist. "It is an important drug — similar to other effective types of radiation treatment, but in an injectable form."

Prostate cancer is the most common type of cancer in the United States, and the second most common cause of cancer death in men.

About Pacific Urology

With clinics in Concord, Walnut Creek, Antioch, Brentwood, San Ramon, and Livermore, Pacific Urology is one of the San Francisco Bay Area's largest urology practices. Pacific Urology restores urologic health for men, women and children, and treats numerous health issues including prostate cancer and treatment, vasectomy and vasectomy reversal, kidney stones, bladder and kidney cancer, erectile dysfunction, incontinence, infertility and more. www.PacificUrology.com

About Diablo Valley Oncology

Diablo Valley Oncology/Hematology Medical Group and their imaging center, California Care Imaging Center are located at the state-of the art California Cancer and Research Institute in Pleasant Hill, CA. They bring together medical oncology, hematology, chemotherapy, radiation therapy, diagnostic imaging, clinical trial, physical therapy and supportive care all in one convenient location. www.DVOHMG.com

MEDIA CONTACT: Paul Kellogg Multimedia PR Manager (303) 552-6510

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson Controls FY26 Results Highlight Growth Momentum

Updated Category News Views 141

Unpacking Johnson Controls' Fiscal 2026 Performance You know, it's not often that a company hits a home run with back-to-back quarters, but Johnson Controls (NYSE:JCI) seems to be swinging for the fences as they wrap up fiscal 2026. What we've got here is a robust set of financial results, showcasing not just growth but momentum that's got investors humming. We're talking...

Continue Reading
EZRA Loop Fuses Human Insight and AI for Managers

Updated Category News Views 134

Hybrid Coaching: The Future is Here If someone told me five years ago that human coaches and AI would team up to churn out better business leaders, I'd have a laugh. But here we are with EZRA Loop, an inventive mix of flesh-and-blood wisdom and algorithmic precision hitting the streets. This might seem like the latest buzzword pie in the sky to some, but there's a real...

Continue Reading
IBM Targets AI Agent Security with New Releases

Updated Category News Views 185

The AI Agent Surge: A Governance Challenge Platforms are hungry for AI agents, but enterprises are drowning in a sea of responsibilities. They bring in these digital workers, pumping them up like competitors puffing their chests. But there's a hitch: you can’t let these agents run wild in sensitive systems, or it’ll be chaos—like letting a bull loose in a china...

Continue Reading
Ensign Group Faces Securities Fraud Lawsuit Amid Scandal

Updated Category News Views 34

Ensign's Legal Storm: Investors on Edge Man, you can't ignore the weighty allegations pounding on Ensign Group's door right now. The skilled nursing giant, under the ticker NASDAQ:ENSG, is feeling the heat from a securities class action filed against them, and my gut tells me this isn't going to blow over quietly. This case sure looks like a financial tempest that could...

Continue Reading
SoftwareOne Secures Leadership in Gartner Report Again

Updated Category News Views 130

A Glance at SoftwareOne's Unyielding Dominance Call it a streak, call it consistency—either way, SoftwareOne's nailed it yet again, bagging the Leader spot in Gartner's Magic Quadrant for SAM Managed Services for the seventh straight year. Yep, seven years running. This ain't just a piece of paper to hang on the office wall. It's a testament to their grit in helping...

Continue Reading
Midland, Michigan Tops 2027 Retirement Destinations

Updated Category News Views 240

Down-to-Earth Findings for Retirees in 2027 Look, when we're talking about settling down after years of the daily grind, it's crystal clear what folks really care about: not blowing through their savings in a heartbeat. No wonder Midland, Michigan, nailed the No. 1 spot yet again in U.S. News & World Report's 2027 Best Places to Retire. And this ain't just a fluke; they...

Continue Reading
Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 7

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
Perpetua Wins $40M U.S. Army Deal: Eyes Tungsten Boost

Updated Category News Views 94

Perpetua's Strategic Move in Mineral Exploration Forget the sleazy diner talk for a sec. We're diving into a strategic American push to revive homegrown tungsten supply. Perpetua Resources is dancing a new jig with a solid $40 million award from the U.S. Army, assisting in this military-driven goal through the Defense Ordnance Technology Consortium. Talk about a smart...

Continue Reading
Pizza & Hope: Little Caesars Serves WV Communities

Updated Category News Views 125

Rolling Out Dough and Kindness in West Virginia In a world that's more uncertain than a penny stock, here comes a story that'll warm even the coldest heart: Little Caesars is sending their Love Kitchen into West Virginia, aiming to serve piping hot pizza to about 8,000 folks in need. Fueled by the efforts of local franchisee Vicki Dunn-Marshall and her team, they're...

Continue Reading
China Leads Electrification; US Faces Stagnation Risk

Updated Category News Views 155

China Races Ahead in Electrification If you ever doubted China's resolve to lead the green charge, the latest Electrification Competitiveness Index should make you think again. They're pacing ahead, while the rest of the world seems content with playing catch-up. Created by the savvy folks over at We Mean Business Coalition with RMI's backing, this index sizes up the...

Continue Reading

Top 5 Most Recently Viewed Articles

Unveiling the DTEN D7X 27: A Game-Changer for Collaboration

Updated Category News Views 206

DTEN D7X 27 Released as a Premier Collaboration Device DTEN, a leading name in video conferencing and collaboration technology, has recently launched the DTEN D7X 27. This innovative device is designed to optimize collaboration in huddle rooms, kiosks, and various workspaces that have limited space. The device is a significant step forward, elevating the collaboration...

Continue Reading
Baird Raises Price Target for S&P Global on Positive Performance

Updated Category News Views 184

Overview of S&P Global's Recent Performance Baird, a well-known financial advisory firm, has recently enhanced its outlook on S&P Global (NYSE: SPGI) shares, increasing the price target from $536 to an impressive $575. This reflects Baird's confidence in the company's overall performance and maintains a status of Outperform for the stock. Analyst Insights on Company...

Continue Reading
Cryptocurrency Market Trends: An Uncertain Path Forward

Updated Category News Views 116

Cryptocurrency Markets Overview In the recent downturn, cryptocurrency markets have slipped significantly. Notably, Bitcoin is struggling to maintain its value near the $110,000 mark, showcasing how volatile the market can be. Ethereum also sees challenges with a current trading price around $4,545.28. As the crypto landscape evolves, each currency is impacted by various...

Continue Reading
Memo Therapeutics Achieves Milestone in Potravitug Trial

Updated Category News Views 180

Significant Milestone Reached in Clinical Trial for Potravitug Schlieren / Zurich, Switzerland – Memo Therapeutics AG (or “MTx”), an innovative biotech company advancing unique immune solutions, proudly announces that it has successfully enrolled the last patient in its extensive Phase II clinical trial for the BK polyomavirus (BKV)-neutralizing antibody,...

Continue Reading
Gee Automotive Companies Shines as a Top Employer on Latest List

Updated Category News Views 179

Gee Automotive Companies Celebrated as a Leading Employer Gee Automotive Companies has recently earned impressive recognition in the realm of employee satisfaction. Garnering the #2 position among extra-large companies on the well-regarded 2025 'Best Places to Work in Washington' list, this honor reflects the company's unyielding commitment to creating an exceptional work...

Continue Reading